Price $7.56 |
Market Cap
402.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.62
|
P/S
-
|
Dividend %
-
|
|
P/CF
6.6
|
P/FCF
-
|
Op. Cash Flow
-75.8K
|
FCF
-1.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-68.70%
|
ROI
-
|
|
ROA
-58.30%
|
EPS Growth
34.20%
|
Current Ratio
9.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Advanz Pharma Corp Ltd (CXRXF) | $17.39 | - | - | 826.6M | Strong Buy |
| AEterna Zentaris Inc. (USA) (AEZS) | $0.87 | - | - | 131.2M | Strong Buy |
| AmerisourceBergen Corp. (ABC) | $116.52 | - | 1.50% | 24.82B | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.64 | - | - | 1.7B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $22.95 | - | - | 923.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
